Jordan Ward, MD
Dermatology · Thomasville, GANPI 1750874509
Payments from drug & device makers
What this record shows
This record is dominated by grants: $78,792 of the $84,619 with a category attached, or 93.1%. Pfizer accounts for 93.3% of it on its own, with 25 other manufacturers making up the rest. Reporting peaked in 2019 at $78,807 and has fallen 98.4% since, to $1,272 in 2025. Among dermatology clinicians in GA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 207 payments — averaging $408.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$79K
- AbbVie$1K
- Johnson & Johnson$631
- Regeneron Healthcare Solutions, Inc.$629
- Sanofi$523
- Amgen$430
- plus $2K from 20 others
What the payments were for
- Grants$78,79293%
- Food & beverage$5,5387%
- Education$2890%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 10 | $78,942 |
| AbbVie | 45 | $1,218 |
| Johnson & Johnson(2 entities) | 37 | $631 |
| Regeneron Healthcare Solutions, Inc. | 16 | $629 |
| Sanofi | 9 | $523 |
| Amgen | 11 | $430 |
| Lilly USA, LLC | 13 | $277 |
| Janssen Scientific Affairs, LLC | 3 | $277 |
| Boehringer Ingelheim | 5 | $227 |
| UCB, Inc. | 9 | $207 |
| Sun Pharmaceutical Industries Inc. | 8 | $206 |
| Novartis | 6 | $195 |
| LEO Pharma Inc. | 7 | $166 |
| Dermavant Sciences, Inc. | 2 | $161 |
| E.r. Squibb & Sons, L.L.C. | 6 | $143 |
| Incyte Corporation | 4 | $95 |
| Arcutis Biotherapeutics, Inc. | 3 | $51 |
| Verrica Pharmaceuticals Inc. | 2 | $46 |
| Biofrontera Inc. | 2 | $43 |
| Seqirus USA Inc | 2 | $38 |
| Stemline Therapeutics Inc. | 1 | $35 |
| Mayne Pharma Commercial LLC | 2 | $24 |
| Galderma Laboratories, L.p. | 1 | $22 |
| Merck | 1 | $14 |
| Helsinn Therapeutics (U.S.), Inc. | 1 | $13 |
| Phathom Pharmaceuticals, Inc. | 1 | $7 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$84,619 in reported general payments places this provider in the 95th percentile of 345 dermatology providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clobetasol Propionate | 61 | $2,461 |
| Econazole Nitrate | 17 | $824 |
| Imiquimod | 15 | $548 |
| Ketoconazole | 32 | $477 |
| Triamcinolone Acetonide | 50 | $441 |
| Doxycycline Hyclate | 17 | $323 |
| Mupirocin | 11 | $124 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Thomasville
- Firas HougeirDouglasville$3.1M
- David CohenMacon$2.9M
- Zakiya RiceAtlanta$1.1M
- Joseph PayneAtlanta$711K
- Jonathan WeissSnellville$692K
- Jamie WeismanAtlanta$620K
- Mack RachalAtlanta$260K
- Tiffany Clay-RamseyMarietta$207K
- Jessica MercerSnellville$183K
- Sumayah TaliaferroAtlanta$104K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.